Brennan Daniel J.'s Form 4 filing
Boston Scientific Corp (BSX) · filed Feb 13, 2025
- Accession no.
- 0001225208-25-001679
- Filed
- Feb 13, 2025
- Trade date
- Feb 11-12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.59M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brennan Daniel J.CIK 0001595612 | Officer (EVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | Common Stock | AGrant or awardAcquired | +33,944 | $0.00 | $0 | 257,865 | Direct | |
| Feb 11, 2025 | Common Stock | FTax withholdingDisposed | −16,414 | $105.98 | −$1,739,555.72 | 241,451 | Direct | |
| Feb 12, 2025 | Common Stock | MOption exerciseAcquired | +15,087 | $16.31 | +$246,068.97 | 256,538 | Direct | |
| Feb 12, 2025 | Common Stock | SSaleDisposed | −15,087 | $105.07 | −$1,585,191.09 | 241,451 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | MOption exerciseDisposed | −15,087 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.